Empower Advisory Group, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1978885 Greenwood Village, CO

Position in GILD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$900,677

+$52,472 QoQ

Shares Held

7,129

+17.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,121

of 2,266 holders

Holding Since

Mar 2023

14 quarters on record

Healthcare · as of Jun 30, 2026

Empower Advisory Group, LLC holds $946,768,864 across 11 Drug Manufacturers - General names. GILD ranks #8 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	268,075	$321,537,224
2	JNJ	Johnson & Johnson	905,317	$229,923,358
3	ABBV	AbbVie Inc.	507,376	$127,676,096
4	AMGN	Amgen Inc	349,667	$126,621,414
5	PFE	Pfizer Inc	4,830,581	$116,320,390
6	MRK	Merck & Co., Inc.	169,726	$21,809,791
7	AZN	Astrazeneca PLC	5,682	$1,077,420
8	GILD	Gilead Sciences, Inc. This page	7,129	$900,677

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$900,677	7,129	+17.1%	Shares	Sole	2026-08-12
2026-03-31	$848,205	6,086	-31.4%	Shares	Sole	2026-05-14
2025-12-31	$1,088,949	8,872	+66.9%	Shares	Sole	2026-02-12
2025-09-30	$590,076	5,316	+5.9%	Shares	Sole	2025-11-14
2025-06-30	$556,789	5,022	+0.9%	Shares	Sole	2025-08-08
2025-03-31	$557,448	4,975	-19.0%	Shares	Sole	2025-05-09
2024-12-31	$567,521	6,144	-18.5%	Shares	Sole	2025-01-31
2024-09-30	$631,818	7,536	-31.2%	Shares	Sole	2024-11-05
2024-06-30	$751,691	10,956	+48.6%	Shares	Sole	2024-07-25
2024-03-31	$540,218	7,375	-24.7%	Shares	Sole	2024-05-02
2023-12-31	$793,330	9,793	+29.0%	Shares	Sole	2024-02-07
2023-09-30	$568,794	7,590	+1.2%	Shares	Sole	2023-11-06
2023-06-30	$577,947	7,499	-3.6%	Shares	Sole	2023-08-10
2023-03-31	$645,589	7,781	—	Shares	Sole	2023-05-25
No filing history on record for this holder in this stock.